Clinical Trials

Discovery & Development Clinical Trials

Putting Real-World Data to Work

03/09/2023 | Karen Ooms | 4 min read

How do we further integrate real-world data into clinical research and approval processes?

Discovery & Development Drug Delivery

Connected Patient-Centricity

02/07/2023 | Oliver Eden | 5 min read

How digital health technology can help clinical trials be more inclusive and accessible.

Discovery & Development Clinical Trials

Save One Person and You Heal the World

01/30/2023 | Angus Stewart | 8 min read

An inside view on the French pharma company and Swiss NPO working on a treatment for a debilitating rare disease

Business & Regulation Business Practice

It’s a Material World…

01/20/2023 | Angus Stewart | 2 min read

Growth, expansion, and acquisitions in Germany are on the menu for this global testing and safety company – here’s why

Discovery & Development Clinical Trials

Cancer Clinical Trials: The Where’s Waldo? Puzzle No One Wants

12/15/2022 | Selin Kurnaz, Arturo Loaiza-Bonilla | 7 min read

The problem finding eligible patients for oncology clinical trials – and the tech-driven solution

Business & Regulation Profession

Pharma and Fordism

12/09/2022 | Angus Stewart | 10 min read

Sitting Down With… Gen Li, CEO, Phesi

Discovery & Development Clinical Trials

Why Sex Matters in Drug Development

11/22/2022 | Emma Banks | 3 min read

Why conversations on gender in drug development must go further.

Discovery & Development Clinical Trials

Positive Opinion for Regeneron’s Libtayo

11/17/2022 | Rob Coker | 3 min read

Regeneron Pharmaceuticals’ Israel Lowy explains how a positive CHMP opinion can become good news for cancer patients

Discovery & Development Drug Discovery

The End of Alopecia?

11/02/2022 | Robyn Goforth | 3 min read

Insights into the quest to find an effective treatment for this socially painful condition

Business & Regulation Standards & Regulation

Why Only a Collective Approach Can Beat Fake Medicine

11/01/2022 | Géraldine Lissalde-Bonnet | 5 min read

Substandard and falsified medicines are a global threat, but a collective pushback can beat them

2
3
4
5
6
...

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Medicine Maker magazine